Comparison of BAP65, DECAF, PEARL, and MEWS Scores in Predicting Respiratory Support Need in Hospitalized Exacerbation of Chronic Obstructive Lung Disease Patients
Abstract Objective: Prognostic models aid clinical practice with decision-making on treatment and hospitalization in exacerbation of chronic obstructive lung disease (ECOPD). Although there are many studies with prognostic models, diagnostic accuracy is variable within and between models. Subjects a...
Saved in:
Published in | Medical principles and practice Vol. 33; no. 4; pp. 355 - 363 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Basel, Switzerland
S. Karger AG
16.04.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
Objective: Prognostic models aid clinical practice with decision-making on treatment and hospitalization in exacerbation of chronic obstructive lung disease (ECOPD). Although there are many studies with prognostic models, diagnostic accuracy is variable within and between models. Subjects and Methods: We compared the prognostic performance of the BAP65 score, DECAF score, PEARL score, and modified early warning score (MEWS) in hospitalized patients with ECOPD, to estimate ventilatory support need. Results: This cross-sectional study consisted of 139 patients. Patients in need of noninvasive or invasive mechanical ventilation support are grouped as ventilatory support groups (n = 54). Comparison between receiver operating characteristic curves revealed that the DECAF score is significantly superior to the PEARL score (p = 0.04) in discriminating patients in need of ventilatory support. DECAF score with a cutoff value of 1 presented the highest sensitivity and BAP65 score with a cutoff value of 2 presented the highest specificity in predicting ventilatory support need. Multivariable analysis revealed that gender played a significant role in COPD exacerbation outcome, and arterial pCO2 and RDW measurements were also predictors of ventilatory support need. Within severity indexes, only the DECAF score was independently associated with the outcome. One-point increase in DECAF score created a 1.43 times higher risk of ventilatory support need. All severity indexes showed a correlation with age, comorbidity index, and dyspnea. BAP65 and DECAF scores also showed a correlation with length of stay. Conclusion: Objective and practical classifications are needed by clinicians to assess prognosis and initiate treatment accordingly. DECAF score is a strong candidate among severity indexes.
Highlights of the StudyObjective and practical classifications are needed by clinicians in order to assess prognosis and initiate treatment accordingly in exacerbation of chronic obstructive lung disease.DECAF score with a cutoff value of 1 presented the highest sensitivity and BAP65 score with a cutoff value of 2 presented the highest specificity in predicting the need for ventilatory support.One-point increase in DECAF score created a 1.43 times higher risk of need for ventilatory support. |
---|---|
AbstractList | Prognostic models aid clinical practice with decision-making on treatment and hospitalization in exacerbation of chronic obstructive lung disease (ECOPD). Although there are many studies with prognostic models, diagnostic accuracy is variable within and between models.OBJECTIVEPrognostic models aid clinical practice with decision-making on treatment and hospitalization in exacerbation of chronic obstructive lung disease (ECOPD). Although there are many studies with prognostic models, diagnostic accuracy is variable within and between models.We compared the prognostic performance of the BAP65 score, DECAF score, PEARL score, and modified early warning score (MEWS) in hospitalized patients with ECOPD, to estimate ventilatory support need.SUBJECTS AND METHODSWe compared the prognostic performance of the BAP65 score, DECAF score, PEARL score, and modified early warning score (MEWS) in hospitalized patients with ECOPD, to estimate ventilatory support need.This cross-sectional study consisted of 139 patients. Patients in need of noninvasive or invasive mechanical ventilation support are grouped as ventilatory support groups (n = 54). Comparison between receiver operating characteristic curves revealed that the DECAF score is significantly superior to the PEARL score (p = 0.04) in discriminating patients in need of ventilatory support. DECAF score with a cutoff value of 1 presented the highest sensitivity and BAP65 score with a cutoff value of 2 presented the highest specificity in predicting ventilatory support need. Multivariable analysis revealed that gender played a significant role in COPD exacerbation outcome, and arterial pCO2 and RDW measurements were also predictors of ventilatory support need. Within severity indexes, only the DECAF score was independently associated with the outcome. One-point increase in DECAF score created a 1.43 times higher risk of ventilatory support need. All severity indexes showed a correlation with age, comorbidity index, and dyspnea. BAP65 and DECAF scores also showed a correlation with length of stay.RESULTSThis cross-sectional study consisted of 139 patients. Patients in need of noninvasive or invasive mechanical ventilation support are grouped as ventilatory support groups (n = 54). Comparison between receiver operating characteristic curves revealed that the DECAF score is significantly superior to the PEARL score (p = 0.04) in discriminating patients in need of ventilatory support. DECAF score with a cutoff value of 1 presented the highest sensitivity and BAP65 score with a cutoff value of 2 presented the highest specificity in predicting ventilatory support need. Multivariable analysis revealed that gender played a significant role in COPD exacerbation outcome, and arterial pCO2 and RDW measurements were also predictors of ventilatory support need. Within severity indexes, only the DECAF score was independently associated with the outcome. One-point increase in DECAF score created a 1.43 times higher risk of ventilatory support need. All severity indexes showed a correlation with age, comorbidity index, and dyspnea. BAP65 and DECAF scores also showed a correlation with length of stay.Objective and practical classifications are needed by clinicians to assess prognosis and initiate treatment accordingly. DECAF score is a strong candidate among severity indexes.CONCLUSIONObjective and practical classifications are needed by clinicians to assess prognosis and initiate treatment accordingly. DECAF score is a strong candidate among severity indexes. Prognostic models aid clinical practice with decision-making on treatment and hospitalization in exacerbation of chronic obstructive lung disease (ECOPD). Although there are many studies with prognostic models, diagnostic accuracy is variable within and between models. We compared the prognostic performance of the BAP65 score, DECAF score, PEARL score, and modified early warning score (MEWS) in hospitalized patients with ECOPD, to estimate ventilatory support need. This cross-sectional study consisted of 139 patients. Patients in need of noninvasive or invasive mechanical ventilation support are grouped as ventilatory support groups (n = 54). Comparison between receiver operating characteristic curves revealed that the DECAF score is significantly superior to the PEARL score (p = 0.04) in discriminating patients in need of ventilatory support. DECAF score with a cutoff value of 1 presented the highest sensitivity and BAP65 score with a cutoff value of 2 presented the highest specificity in predicting ventilatory support need. Multivariable analysis revealed that gender played a significant role in COPD exacerbation outcome, and arterial pCO2 and RDW measurements were also predictors of ventilatory support need. Within severity indexes, only the DECAF score was independently associated with the outcome. One-point increase in DECAF score created a 1.43 times higher risk of ventilatory support need. All severity indexes showed a correlation with age, comorbidity index, and dyspnea. BAP65 and DECAF scores also showed a correlation with length of stay. Objective and practical classifications are needed by clinicians to assess prognosis and initiate treatment accordingly. DECAF score is a strong candidate among severity indexes. Objective: Prognostic models aid clinical practice with decision-making on treatment and hospitalization in exacerbation of chronic obstructive lung disease (ECOPD). Although there are many studies with prognostic models, diagnostic accuracy is variable within and between models. Subjects and Methods: We compared the prognostic performance of the BAP65 score, DECAF score, PEARL score, and modified early warning score (MEWS) in hospitalized patients with ECOPD, to estimate ventilatory support need. Results: This cross-sectional study consisted of 139 patients. Patients in need of noninvasive or invasive mechanical ventilation support are grouped as ventilatory support groups (n = 54). Comparison between receiver operating characteristic curves revealed that the DECAF score is significantly superior to the PEARL score (p = 0.04) in discriminating patients in need of ventilatory support. DECAF score with a cutoff value of 1 presented the highest sensitivity and BAP65 score with a cutoff value of 2 presented the highest specificity in predicting ventilatory support need. Multivariable analysis revealed that gender played a significant role in COPD exacerbation outcome, and arterial pCO2 and RDW measurements were also predictors of ventilatory support need. Within severity indexes, only the DECAF score was independently associated with the outcome. One-point increase in DECAF score created a 1.43 times higher risk of ventilatory support need. All severity indexes showed a correlation with age, comorbidity index, and dyspnea. BAP65 and DECAF scores also showed a correlation with length of stay. Conclusion: Objective and practical classifications are needed by clinicians to assess prognosis and initiate treatment accordingly. DECAF score is a strong candidate among severity indexes. Abstract Objective: Prognostic models aid clinical practice with decision-making on treatment and hospitalization in exacerbation of chronic obstructive lung disease (ECOPD). Although there are many studies with prognostic models, diagnostic accuracy is variable within and between models. Subjects and Methods: We compared the prognostic performance of the BAP65 score, DECAF score, PEARL score, and modified early warning score (MEWS) in hospitalized patients with ECOPD, to estimate ventilatory support need. Results: This cross-sectional study consisted of 139 patients. Patients in need of noninvasive or invasive mechanical ventilation support are grouped as ventilatory support groups (n = 54). Comparison between receiver operating characteristic curves revealed that the DECAF score is significantly superior to the PEARL score (p = 0.04) in discriminating patients in need of ventilatory support. DECAF score with a cutoff value of 1 presented the highest sensitivity and BAP65 score with a cutoff value of 2 presented the highest specificity in predicting ventilatory support need. Multivariable analysis revealed that gender played a significant role in COPD exacerbation outcome, and arterial pCO2 and RDW measurements were also predictors of ventilatory support need. Within severity indexes, only the DECAF score was independently associated with the outcome. One-point increase in DECAF score created a 1.43 times higher risk of ventilatory support need. All severity indexes showed a correlation with age, comorbidity index, and dyspnea. BAP65 and DECAF scores also showed a correlation with length of stay. Conclusion: Objective and practical classifications are needed by clinicians to assess prognosis and initiate treatment accordingly. DECAF score is a strong candidate among severity indexes. Highlights of the StudyObjective and practical classifications are needed by clinicians in order to assess prognosis and initiate treatment accordingly in exacerbation of chronic obstructive lung disease.DECAF score with a cutoff value of 1 presented the highest sensitivity and BAP65 score with a cutoff value of 2 presented the highest specificity in predicting the need for ventilatory support.One-point increase in DECAF score created a 1.43 times higher risk of need for ventilatory support. Patients with a waiting period in the emergency department for more than 72 h before admission or ICU admission before being admitted to the ward were also excluded from the study. Components of prognostic scores DECAF PEARL BAP-65 NEWS MEWS Dyspnea eMRCD score eMRCD score - - - Blood measurements Eosinophil count <0.05 × 109/L - Urea nitrogen ≥25 mg/dL - - Chest X-ray Consolidation - - - - Blood gas analysis pH <7.30 - - Oxygen saturation - Comorbidities Atrial fibrillation Right heart failure - - - Left heart failure Age - Age >80 Age >65 - - Previous exacerbation - Previous admission >2 - - - Vital signs and mental status - - Heart rate Systolic blood pressure Systolic blood pressure Heart rate Heart rate Respiratory rate Respiratory rate Altered mental status (GKS score) Temperature Temperature AVPU score AVPU score The BAP65 score was developed by Tabak et al. MEWS is validated in medical admissions [14] using systolic blood pressure, heart rate, respiratory rate, temperature, and AVPU score for consciousness. Clinical characteristics and laboratory measurements upon admission (n = 139) Age, years 68.1±8.9 Male gender, n (%) 120 (86.3) Smoking status, n (%) Current smoker 24 (17.3) Ex-smoker 87 (62.6) Never smoker 11 (7.9) Smoking, pack/year 50.0 [30.0–70.0] Comorbidities, n (%) CAD 30 (21.6) HT 51 (36.7) AF 9 (6.5) HF 26 (18.8) DM 28 (20.1) CVD 6 (4.3) CRF 16 (11.5) Bronchiectasis 7 (5.0) Malignancy 12 (8.6) OSA 3 (2.2) Charlson comorbidity index 2.0 [1.0–4.0] Duration of COPD diagnosis, years 7.0 [3.0–10.0] All ECOPD episodes in the last year 2.0 [1.0–3.0] Hospitalization in the last year 1.0 [0.0–1.7] ED visit in the last year 2.5 [1.0–4.0] Home LTOT, n (%) 54 (38.8) eMRC 3.0 [2.0–4.0] Laboratory measurements White blood cell count, 109/L 9.15 [6.86–12.98] Eosinophil count, 106/L 68.5 [13.0–194.2] RDW 13.3 [12.0–15.0] BNP, ng/L 82.0 [36.2–385.0] Albumin, g/L 34.8±5.2 Arterial blood gas analysis pH 7.39±0.07 pO2, mm Hg 65.0 [50.4–82.7] pCO2, mm Hg 47.0 [37.4–59.0] HCO3, mmol/L 26.9 [24.0–30.8] CRP at admission, mg/L 13.4 [4.6–90.7] Procalcitonin at admission, µg/L 0.07 [0.03–0.23] Severity indexes BAP 65 score 1.0 [1.0–2.0] Class 1 20 (14.4) Class 2 47 (33.8) Class 3 34 (24.5) Class 4 10 (7.2) Class 5 1 (0.7) PEARL score 2.0 [1.0–4.0] Low risk, n (%) 52 (37.4) Intermediate risk, n (%) 51 (36.7) High risk, n (%) 20 (14.4) DECAF score 1.0 [1.0–2.0] MEWS |
Author | Aydin-Güçlü, Özge Ursavaş, Ahmet Yildiz, Merve Nur Karadağ, Mehmet Uzaslan, Esra Acet-Öztürk, Nilüfer Aylin Demirdöğen, Ezgi Görek Dilektaşli, Aslı Coşkun, Funda |
Author_xml | – sequence: 1 givenname: Nilüfer Aylin surname: Acet-Öztürk fullname: Acet-Öztürk, Nilüfer Aylin email: *Nilüfer Aylin Acet-Öztürk, niluferacet@gmail.com – sequence: 2 givenname: Özge surname: Aydin-Güçlü fullname: Aydin-Güçlü, Özge – sequence: 3 givenname: Merve Nur surname: Yildiz fullname: Yildiz, Merve Nur – sequence: 4 givenname: Ezgi surname: Demirdöğen fullname: Demirdöğen, Ezgi – sequence: 5 givenname: Aslı surname: Görek Dilektaşli fullname: Görek Dilektaşli, Aslı – sequence: 6 givenname: Funda surname: Coşkun fullname: Coşkun, Funda – sequence: 7 givenname: Esra surname: Uzaslan fullname: Uzaslan, Esra – sequence: 8 givenname: Ahmet surname: Ursavaş fullname: Ursavaş, Ahmet – sequence: 9 givenname: Mehmet surname: Karadağ fullname: Karadağ, Mehmet |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38626747$$D View this record in MEDLINE/PubMed |
BookMark | eNpt0k1v1DAQBuAIFdEPOHBHyFIvIO2CHSe2c0JLuqVIWxp1QRwjx55s3e7awU4qyt_hj-IqJQLEybbm0Tu2PIfJnnUWkuQ5wW8IyYu3GOOcCkHSR8kByVI6xyQne3GPCZnznJP95DCE68gEpfhJsk8FSxnP-EHys3S7TnoTnEWuRe8XFctn6GRZLk5nqFouLlczJK1G58uva7RWzkNAxqLKgzaqN3aDLiF0xsve-Tu0HrrO-R59AtD37MzFWi-35kc8L79LBb6RvRl7lVfeWaPQRRN6P8SwW0CrISaemAAyAKoiBduHp8njVm4DPHtYj5Ivp8vP5dl8dfHhY7lYzVUmcD8v2jaXjGSFxiwjkjcSUi5zpRgXTDPGsBCt4LhgDQGhtRRNw2mqW61SoBroUfJuzO2GZgdaxd5ebuvOm530d7WTpv67Ys1VvXG3NSFpjnPMY8KrhwTvvg0Q-npngoLtVlpwQ6gpzjBNScZZpMf_0Gs3eBvfF1VB4zOKrIjq5Z9Xmu7y-wMjeD0C5V0IHtqJEFzfD0c9DUe0L0Z7I_0G_CSn8vF_y-dVNYq60y39BTIQwKI |
Cites_doi | 10.1016/j.rmed.2013.01.007 10.3111/13696998.2013.800525 10.1080/15412555.2021.1959540 10.1136/thoraxjnl-2016-209298 10.1111/crj.13028 10.1093/qjmed/94.10.521 10.1183/23120541.00436-2022 10.1136/bmj.l5358 10.1016/j.jcrc.2012.02.015 10.26355/eurrev_202106_26045 10.1111/crj.12973 10.1136/thoraxjnl-2017-211197 10.1136/thoraxjnl-2019-213470 10.1016/j.ejim.2018.10.018 10.1136/thoraxjnl-2012-202103 10.4266/kjccm.2013.28.4.255 10.1080/17476348.2021.1901584 10.1378/chest.10-3035 10.1183/13993003.02426-2016 10.1136/thoraxjnl-2015-207775 10.1136/thoraxjnl-2019-213788 10.1001/archinternmed.2009.270 |
ContentType | Journal Article |
Copyright | 2024 The Author(s). Published by S. Karger AG, Basel 2024 The Author(s). Published by S. Karger AG, Basel. 2024 The Author(s). Published by S. Karger AG, Basel. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at: https://uk.sagepub.com/en-gb/eur/reusing-open-access-and-sage-choice-content 2024 The Author(s). Published by S. Karger AG, Basel 2024 |
Copyright_xml | – notice: 2024 The Author(s). Published by S. Karger AG, Basel – notice: 2024 The Author(s). Published by S. Karger AG, Basel. – notice: 2024 The Author(s). Published by S. Karger AG, Basel. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at: https://uk.sagepub.com/en-gb/eur/reusing-open-access-and-sage-choice-content – notice: 2024 The Author(s). Published by S. Karger AG, Basel 2024 |
DBID | M-- AAYXX CITATION NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.1159/000538812 |
DatabaseName | Karger Open Access Journals CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed CrossRef ProQuest One Academic Middle East (New) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: M-- name: Karger Open Access Journals url: https://www.karger.com/OpenAccess sourceTypes: Enrichment Source Publisher – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Comparison of BAP65, DECAF, PEARL, and MEWS Scores in COPD Exacerbation |
EISSN | 1423-0151 |
EndPage | 363 |
ExternalDocumentID | PMC11250507 38626747 10_1159_000538812 538812 |
Genre | Journal Article |
GroupedDBID | --- 0R~ 0~B 326 36B 3O. 4.4 53G 5GY 7X7 88E 8FI 8FJ 8UI AAWTL AAYIC ABBTS ABPAZ ABUWG ABWCG ACGFS ADBBV AENEX AEYAO AFKRA AHFRZ AHMBA ALDHI ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZPMC BAWUL BCNDV BENPR BPHCQ BVXVI CCPQU CS3 DIK DU5 E0A E3Z EBS EMB EMOBN F5P FB. FYUFA GROUPED_DOAJ HMCUK HYE HZ~ IAO IHR ITC KUZGX M-- M1P MK0 O1H O9- OK1 P2P PHGZT PQQKQ PROAC PSQYO RKO RNS RPM SV3 UJ6 UKHRP 30W AAYXX ACQXL ADAGL AFJJK AFSIO AIOBO CAG CITATION COF CYUIP EJD PHGZM RIG RXVBD TR2 NPM PJZUB PPXIY 3V. 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c480t-9ff5a6149d0641a7bae27a5cc6786d666088f87096b1e8dda8bb732dfdc2e3de3 |
IEDL.DBID | 7X7 |
ISSN | 1011-7571 1423-0151 |
IngestDate | Thu Aug 21 18:33:54 EDT 2025 Fri Jul 11 00:54:01 EDT 2025 Wed Aug 13 06:41:48 EDT 2025 Mon Jul 21 06:04:20 EDT 2025 Tue Jul 01 04:55:31 EDT 2025 Fri Apr 25 05:07:09 EDT 2025 Fri Apr 25 05:07:44 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Chronic obstructive lung disease exacerbation Hospitalization Severity indexes Respiratory support |
Language | English |
License | This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. https://creativecommons.org/licenses/by-nc/4.0 2024 The Author(s). Published by S. Karger AG, Basel. This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c480t-9ff5a6149d0641a7bae27a5cc6786d666088f87096b1e8dda8bb732dfdc2e3de3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://karger.com/doi/10.1159/000538812 |
PMID | 38626747 |
PQID | 3093149949 |
PQPubID | 2047984 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_3040321476 crossref_primary_10_1159_000538812 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11250507 karger_primary_538812 pubmed_primary_38626747 proquest_journals_3093149949 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-04-16 |
PublicationDateYYYYMMDD | 2024-04-16 |
PublicationDate_xml | – month: 04 year: 2024 text: 2024-04-16 day: 16 |
PublicationDecade | 2020 |
PublicationPlace | Basel, Switzerland |
PublicationPlace_xml | – name: Basel, Switzerland – name: Switzerland – name: Basel |
PublicationTitle | Medical principles and practice |
PublicationTitleAlternate | Med Princ Pract |
PublicationYear | 2024 |
Publisher | S. Karger AG |
Publisher_xml | – name: S. Karger AG |
References | Tabak YP, Sun X, Johannes RS, Gupta V, Shorr AF. Mortality and need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: development and validation of a simple risk score. Arch Intern Med. 2009;169(17):1595–602. Lane ND, Gillespie SM, Steer J, Bourke SC. Uptake of clinical prognostic tools in COPD exacerbations requiring hospitalisation. COPD. 2021;18(4):406–10. Unal A, Bayram B, Ergan B, Can K, Ergun YK, Kilinc O. Comparison of two scores for short-term outcomes in patients with COPD exacerbation in the emergency department: the Ottawa COPD Risk Scale and the DECAF score. ERJ Open Res. 2023;9(2):00436–2022. Son JH, Lee JY, Yang YM, Sung WY, Seo SW, Kim JC, . Utility of the DECAF score in patients admitted to emergency department with acute exacerbation of chronic obstructive pulmonary disease. Korean J Crit Care Med. 2013;28(4):255–65. Germini F, Veronese G, Marcucci M, Coen D, Ardemagni D, Montano N, . Validation of the BAP-65 score for prediction of in-hospital death or use of mechanical ventilation in patients presenting to the emergency department with an acute exacerbation of COPD: a retrospective multi-center study from the Italian Society of Emergency Medicine (SIMEU). Eur J Intern Med. 2019;61:62–8. Vogelmeier C, Chair, Agusti A, Anzueto A, Barnes P, Bourbeau J, . The global strategy for diagnosis, management and prevention of COPD (GOLD) 2023 report. https://goldcopd.org/2023-gold-report-2/Date (last accessed August 30, 2023). Bellou V, Belbasis L, Konstantinidis AK, Tzoulaki I, Evangelou E. Prognostic models for outcome prediction in patients with chronic obstructive pulmonary disease: systematic review and critical appraisal. BMJ. 2019;367:l5358. Shorr AF, Sun X, Johannes RS, Yaitanes A, Tabak YP. Validation of a novel risk score for severity of illness in acute exacerbations of COPD. Chest. 2011;140(5):1177–83. Shafuddin E, Chang CL, Hancox RJ. Comparing severity scores in exacerbations of chronic obstructive pulmonary disease. Clin Respir J. 2018;12(12):2668–75. de Miguel-Díez J, Jiménez-García R, Hernández-Barrera V, Puente-Maestu L, Rodríguez-Rodríguez P, López de Andrés A, . Trends in hospital admissions for acute exacerbation of COPD in Spain from 2006 to 2010. Respir Med. 2013;107(5):717–23. Suh ES, Sage B. COPD exacerbations: 2 much NEWS. Thorax. 2019;74(10):929–30. Echevarria C, Steer J, Heslop-Marshall K, Stenton SC, Hickey PM, Hughes R, . The PEARL score predicts 90-day readmission or death after hospitalisation for acute exacerbation of COPD. Thorax. 2017;72(8):686–93. Shorr AF, Sun X, Johannes RS, Derby KG, Tabak YP. Predicting the need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: comparing the CURB-65 and BAP-65 scores. J Crit Care. 2012;27(6):564–70. Rochwerg B, Brochard L, Elliott MW, Hess D, Hill NS, Nava S, . Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J. 2017;50(2):1602426. Steer J, Gibson J, Bourke SC. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax. 2012;67(11):970–6. Echevarria C, Gray J, Hartley T, Steer J, Miller J, Simpson AJ, . Home treatment of COPD exacerbation selected by DECAF score: a non-inferiority, randomised controlled trial and economic evaluation. Thorax. 2018;73(8):713–22. Shen MH, Qiu GQ, Wu XM, Dong MJ. Utility of the DECAF score for predicting survival of patients with COPD: a meta-analysis of diagnostic accuracy studies. Eur Rev Med Pharmacol Sci. 2021;25(11):4037–50. Gayaf M, Karadeniz G, Güldaval F, Polat G, Türk M. Which one is superior in predicting 30 and 90 days mortality after COPD exacerbation: DECAF, CURB-65, PSI, BAP-65, PLR, NLR. Expert Rev Respir Med. 2021;15(6):845–51. Echevarria C, Steer J, Heslop-Marshall K, Stenton SC, Hickey PM, Hughes R, . Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD. Thorax. 2016;71(2):133–40. Johannesdottir SA, Christiansen CF, Johansen MB, Olsen M, Xu X, Parker JM, . Hospitalization with acute exacerbation of chronic obstructive pulmonary disease and associated health resource utilization: a population-based Danish cohort study. J Med Econ. 2013;16(7):897–906. Shi QF, Sheng Y, Zhu N, Tan Y, Xie XH, Wang SY, . The v-DECAF score can predict 90-day all-cause mortality in patients with COPD exacerbation requiring invasive mechanical ventilation. Clin Respir J. 2019;13(7):438–45. Subbe CP, Kruger M, Rutherford P, Gemmel L. Validation of a modified early warning score in medical admissions. QJM. 2001;94(10):521–6. Echevarria C, Steer J, Bourke SC. Comparison of early warning scores in patients with COPD exacerbation: DECAF and NEWS score. Thorax. 2019;74(10):941–6. ref13 ref12 ref15 ref14 ref20 ref11 ref22 ref10 ref21 ref2 ref1 ref17 ref16 ref19 ref18 ref8 ref7 ref9 ref4 ref3 ref6 ref5 |
References_xml | – reference: Rochwerg B, Brochard L, Elliott MW, Hess D, Hill NS, Nava S, . Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J. 2017;50(2):1602426. – reference: Lane ND, Gillespie SM, Steer J, Bourke SC. Uptake of clinical prognostic tools in COPD exacerbations requiring hospitalisation. COPD. 2021;18(4):406–10. – reference: Suh ES, Sage B. COPD exacerbations: 2 much NEWS. Thorax. 2019;74(10):929–30. – reference: Vogelmeier C, Chair, Agusti A, Anzueto A, Barnes P, Bourbeau J, . The global strategy for diagnosis, management and prevention of COPD (GOLD) 2023 report. https://goldcopd.org/2023-gold-report-2/Date (last accessed August 30, 2023). – reference: Shorr AF, Sun X, Johannes RS, Derby KG, Tabak YP. Predicting the need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: comparing the CURB-65 and BAP-65 scores. J Crit Care. 2012;27(6):564–70. – reference: Shorr AF, Sun X, Johannes RS, Yaitanes A, Tabak YP. Validation of a novel risk score for severity of illness in acute exacerbations of COPD. Chest. 2011;140(5):1177–83. – reference: Shi QF, Sheng Y, Zhu N, Tan Y, Xie XH, Wang SY, . The v-DECAF score can predict 90-day all-cause mortality in patients with COPD exacerbation requiring invasive mechanical ventilation. Clin Respir J. 2019;13(7):438–45. – reference: Echevarria C, Steer J, Heslop-Marshall K, Stenton SC, Hickey PM, Hughes R, . The PEARL score predicts 90-day readmission or death after hospitalisation for acute exacerbation of COPD. Thorax. 2017;72(8):686–93. – reference: Gayaf M, Karadeniz G, Güldaval F, Polat G, Türk M. Which one is superior in predicting 30 and 90 days mortality after COPD exacerbation: DECAF, CURB-65, PSI, BAP-65, PLR, NLR. Expert Rev Respir Med. 2021;15(6):845–51. – reference: Germini F, Veronese G, Marcucci M, Coen D, Ardemagni D, Montano N, . Validation of the BAP-65 score for prediction of in-hospital death or use of mechanical ventilation in patients presenting to the emergency department with an acute exacerbation of COPD: a retrospective multi-center study from the Italian Society of Emergency Medicine (SIMEU). Eur J Intern Med. 2019;61:62–8. – reference: Echevarria C, Steer J, Bourke SC. Comparison of early warning scores in patients with COPD exacerbation: DECAF and NEWS score. Thorax. 2019;74(10):941–6. – reference: Tabak YP, Sun X, Johannes RS, Gupta V, Shorr AF. Mortality and need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: development and validation of a simple risk score. Arch Intern Med. 2009;169(17):1595–602. – reference: Shafuddin E, Chang CL, Hancox RJ. Comparing severity scores in exacerbations of chronic obstructive pulmonary disease. Clin Respir J. 2018;12(12):2668–75. – reference: Johannesdottir SA, Christiansen CF, Johansen MB, Olsen M, Xu X, Parker JM, . Hospitalization with acute exacerbation of chronic obstructive pulmonary disease and associated health resource utilization: a population-based Danish cohort study. J Med Econ. 2013;16(7):897–906. – reference: Echevarria C, Gray J, Hartley T, Steer J, Miller J, Simpson AJ, . Home treatment of COPD exacerbation selected by DECAF score: a non-inferiority, randomised controlled trial and economic evaluation. Thorax. 2018;73(8):713–22. – reference: Unal A, Bayram B, Ergan B, Can K, Ergun YK, Kilinc O. Comparison of two scores for short-term outcomes in patients with COPD exacerbation in the emergency department: the Ottawa COPD Risk Scale and the DECAF score. ERJ Open Res. 2023;9(2):00436–2022. – reference: de Miguel-Díez J, Jiménez-García R, Hernández-Barrera V, Puente-Maestu L, Rodríguez-Rodríguez P, López de Andrés A, . Trends in hospital admissions for acute exacerbation of COPD in Spain from 2006 to 2010. Respir Med. 2013;107(5):717–23. – reference: Steer J, Gibson J, Bourke SC. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax. 2012;67(11):970–6. – reference: Subbe CP, Kruger M, Rutherford P, Gemmel L. Validation of a modified early warning score in medical admissions. QJM. 2001;94(10):521–6. – reference: Shen MH, Qiu GQ, Wu XM, Dong MJ. Utility of the DECAF score for predicting survival of patients with COPD: a meta-analysis of diagnostic accuracy studies. Eur Rev Med Pharmacol Sci. 2021;25(11):4037–50. – reference: Bellou V, Belbasis L, Konstantinidis AK, Tzoulaki I, Evangelou E. Prognostic models for outcome prediction in patients with chronic obstructive pulmonary disease: systematic review and critical appraisal. BMJ. 2019;367:l5358. – reference: Son JH, Lee JY, Yang YM, Sung WY, Seo SW, Kim JC, . Utility of the DECAF score in patients admitted to emergency department with acute exacerbation of chronic obstructive pulmonary disease. Korean J Crit Care Med. 2013;28(4):255–65. – reference: Echevarria C, Steer J, Heslop-Marshall K, Stenton SC, Hickey PM, Hughes R, . Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD. Thorax. 2016;71(2):133–40. – ident: ref2 doi: 10.1016/j.rmed.2013.01.007 – ident: ref1 doi: 10.3111/13696998.2013.800525 – ident: ref14 doi: 10.1080/15412555.2021.1959540 – ident: ref11 doi: 10.1136/thoraxjnl-2016-209298 – ident: ref10 doi: 10.1111/crj.13028 – ident: ref13 doi: 10.1093/qjmed/94.10.521 – ident: ref17 doi: 10.1183/23120541.00436-2022 – ident: ref3 doi: 10.1136/bmj.l5358 – ident: ref21 doi: 10.1016/j.jcrc.2012.02.015 – ident: ref20 doi: 10.26355/eurrev_202106_26045 – ident: ref19 doi: 10.1111/crj.12973 – ident: ref16 doi: 10.1136/thoraxjnl-2017-211197 – ident: ref15 doi: 10.1136/thoraxjnl-2019-213470 – ident: ref7 doi: 10.1016/j.ejim.2018.10.018 – ident: ref8 doi: 10.1136/thoraxjnl-2012-202103 – ident: ref22 doi: 10.4266/kjccm.2013.28.4.255 – ident: ref18 doi: 10.1080/17476348.2021.1901584 – ident: ref6 doi: 10.1378/chest.10-3035 – ident: ref4 doi: 10.1183/13993003.02426-2016 – ident: ref9 doi: 10.1136/thoraxjnl-2015-207775 – ident: ref12 doi: 10.1136/thoraxjnl-2019-213788 – ident: ref5 doi: 10.1001/archinternmed.2009.270 |
SSID | ssj0008330 |
Score | 2.3258784 |
Snippet | Abstract
Objective: Prognostic models aid clinical practice with decision-making on treatment and hospitalization in exacerbation of chronic obstructive lung... Objective: Prognostic models aid clinical practice with decision-making on treatment and hospitalization in exacerbation of chronic obstructive lung disease... Prognostic models aid clinical practice with decision-making on treatment and hospitalization in exacerbation of chronic obstructive lung disease (ECOPD).... Patients with a waiting period in the emergency department for more than 72 h before admission or ICU admission before being admitted to the ward were also... |
SourceID | pubmedcentral proquest pubmed crossref karger |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 355 |
SubjectTerms | Age Blood pressure Cardiac arrhythmia Chronic obstructive pulmonary disease Clinical medicine Comorbidity Consciousness Dyspnea Emergency medical care Heart failure Heart rate Hospitalization Intensive care Lung diseases Mortality Original Paper Oxygen saturation Patients Risk factors Statistical analysis Steroids Variables Ventilators |
SummonAdditionalLinks | – databaseName: Karger Open Access Journals dbid: M-- link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1Nb9QwELVQQVUviI8CgYIGxHEtJbETx8dlm1WFmhK1VPQWObGjrpCyFdtWiL_DH2UmTkK3gmPiL1nP9rzJOG8Y-6idaSMha26tTLhstOF15BSPkTugiy1tK-lv5OIkPTqXny-Si-F7B_0L853uP_fSqJO2ABrcPvWcyDJKJ_wQ_ShBKvkF59OZmwnhdQeiiKtERYOG0FbTPbYriL8rSqVyxwg98mP-i2Levyl5x_Qsn7DHA2eEuQf5KXvgumdstxii4s_Z78WUTBDWLXyal2kyg8N8MV_OoMznp8czMJ2FIv92BmekW7mBVQflD-qBrj3D6d-AO1CeT-TkcIJ2jaqNmUVWv_A5_2kaBKKHk8YatHXhSz0I0d46OMbzAw594AdKr9u62Wfny_zr4ogPyRd4I7Pwmuu2TQzabm2RtERG1cbFyiRNg9Yttej04PHU4mbXKWKbWWuyulYitq1tYiesEy_YTrfu3CsGsWgSaY3EfqxMQ2EkenE6VaGjxsYG7MOIRnXlNTaq3jdJdDWhF7B9j9NUZXx_cO99UZa-qLqyLRaPqFbD7txUFP3FmWmpA_Z-KsZ9RcES07n1DdWRYZ_EKQ3YS78IphHGZRSwbGt5TBVIs3u7pFtd9trdSG-Rc4bq9X-m84btxUibKF4VpQdsB7Fzb5H2XNfv-hX_B3yP-04 priority: 102 providerName: Karger AG |
Title | Comparison of BAP65, DECAF, PEARL, and MEWS Scores in Predicting Respiratory Support Need in Hospitalized Exacerbation of Chronic Obstructive Lung Disease Patients |
URI | https://karger.com/doi/10.1159/000538812 https://www.ncbi.nlm.nih.gov/pubmed/38626747 https://www.proquest.com/docview/3093149949 https://www.proquest.com/docview/3040321476 https://pubmed.ncbi.nlm.nih.gov/PMC11250507 |
Volume | 33 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1db9MwFLVgQ4gXxMcYGaMyiMdaJLETx0-o61JNaClRx0TfIid2RIWUlnVMiL_DH-XexMnohHiJlNj5kI7te67vzbmEvFNW1wEXJTNGRExUSrMysJKFwB3AxRamFvg3cjaPzy7Fx2W0dBtuW5dW2a-J7UJt1hXukb_HiB2weSXUh813hlWjMLrqSmjcJ_soXYYpXXI5OFzALninRhAETEYycMpCYMHbWnY8SYJwxx49-Ibp11f_Ypt3kyb_skKzJ-Sxo4900uH9lNyzzTPyMHMB8ufk93SoK0jXNT2Z5HE0pqfpdDIb0zydLM7HVDeGZumXC3qBEpZbumpofoVPwAxouriNvVMs-Qn0nM7BxGG3vsjI6hecpz91BZi0yOK7nMwu_VQ6TdobS89hKaGnXQyI5p2E6_aAXM7Sz9Mz5uowsEok_jVTdR1pMOPKAH8JtCy1DaWOqgoMXWzA_4GVqoZ5r2KAOTFGJ2UpeWhqU4WWG8tfkL1m3diXhIa8ioTRAp5jROxzLcChU7H0Ld6sjUfe9mgUm05uo2jdlEgVA2QeOehwGrr014_vXM_yvGsqNqaG5h7Vwk3UbXE7rDzyZmiGKYZxE93Y9Q_sI_y2nlPskcNuEAxv4OgRgkvmkWRneAwdUL57t6VZfW1lvIHpAv305dH_v-sVeRQCkcIIVhAfkz2A0L4GInRdjtrRPiL7J-k8X4za7QQ4Zoz9AQdKCjc |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VFAEXxKOAocCA4BYL27t-HRBKE0cpjYOVtqI3s_auRYTkhKY8_w53fiOzfpVUiFuP8W7WlubbmW88628AXoRKFDbjmSkld02eh8LMbOWbDnEHSrG5LLj-GjmeeZNj_vbEPdmC3-23MPpYZesTK0ctl7l-R_5KV-yIzYc8fLP6bOquUbq62rbQqGFxoH58o5Rt_Xp_RPZ96Tjj6Gg4MZuuAmbOA-vMDIvCFRSUQknR2BZ-JpTjCzfPyW17ktg87buCUBx69NCBlCLIMp85spC5o5hUjNa9AtucUSrTg-29aJbMO98fMFbrH9i26bu-3WgZEWeouuexILCdjQh49ZM-8H36L3578ZjmX3FvfAtuNoQVBzXCbsOWKu_Atbgpyd-FX8OukyEuC9wbJJ7bx1E0HIz7mESD-bSPopQYR-8P8VCLZq5xUWJyqlfQZ65xfl7tR91klBICnFFQ1dPatiaLn_Q7-i5yQkGFJX2vRtgX32WNCu5XhVNyXjiqq06Y1KKx6x04vhQb3YNeuSzVA0CH5S6XgtM6knsWE5xSyNDzLaX_LKQBz1trpKta4COtEiM3TDuTGbBT26mb0l7fvXA9TpJ6KF3JgoZbq6aNa1in50A24Fk3TJtaV2pEqZZf9BxuVR2kPAPu1yDo7sB0DkpJoAHBBjy6CVowfHOkXHyshMOJWxPhtfyH_3-up3B9chRP0-n-7OAR3HCIxun6me3tQo_MqR4TDTvLnjTYR_hw2dvtD1-HRjU |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VgqpeEI8ChgILglus2t611z4gFBJHLU2C1VKRm1l712qE5ISmPP8O_4Jfx4xfJRXi1mO8m3WieX3jGX8D8CIyqnC5yGythW-LPFJ25hppe4gdMMUWuhD0NvJkGuyfiLczf7YBv9t3YaitsvWJlaPWi5yeke9RxQ7RfCSivaJpi0iGo9fLzzZNkKJKaztOo1aRQ_PjG6Zvq1cHQ5T1S88bxe8H-3YzYcDOReic21FR-AoDVKQxMrtKZsp4Uvl5ji480Ijs0QYL1OgowD8Qaq3CLJPc04XOPcO14XjuNbguue-SjclZl-whsuE1E4Lr2tKXbsNqhOihmqPHw9D11mLhjU_U-n32L6R7uWHzrwg4ugU3G-jK-rWu3YYNU96BrUlTnL8LvwbdTEO2KNibfhL4PTaMB_1RjyVx_2jcY6rUbBJ_OGbHRJ-5YvOSJWd0AnVfs6OLuj-jcaOYGrAphlfa1g44mf_Ez_F3laM-VFpF92ooftm7rOHD_WrYGN0YG9b1J5bU9LGrHTi5Egndg81yUZoHwDye-0IrgedoEThcCUwmo0A6hr6stAXPW2mky5rqI61SJD9KO5FZsFPLqdvSXt-9dH2SJPVSutQFLrdSTRsnsUovVNqCZ90ymjfVbFRpFl9oj3CqWVKBBfdrJejuwCkbxXTQgnBNPboNRB2-vlLOTysKcUTZCH0d-fD_v-spbKGRpeOD6eEj2PYQz1EhzQ12YROlaR4jHjvPnlSKz-DjVVvaH-lfSQU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+BAP65%2C+DECAF%2C+PEARL%2C+and+MEWS+Scores+in+Predicting+Respiratory+Support+Need+in+Hospitalized+Exacerbation+of+Chronic+Obstructive+Lung+Disease+Patients&rft.jtitle=Medical+principles+and+practice&rft.au=Acet-%C3%96zt%C3%BCrk%2C+Nil%C3%BCfer+Aylin&rft.au=Aydin-G%C3%BC%C3%A7l%C3%BC%2C+%C3%96zge&rft.au=Yildiz%2C+Merve+Nur&rft.au=Demird%C3%B6%C4%9Fen%2C+Ezgi&rft.date=2024-04-16&rft.issn=1423-0151&rft.eissn=1423-0151&rft.spage=1&rft_id=info:doi/10.1159%2F000538812&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1011-7571&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1011-7571&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1011-7571&client=summon |